AdaptivCRT algorithm in Viva CRT-D and CRT-P defibrillators saves hospital costs- Medtronic

New data from the Medtronic, Inc. Adaptive CRT trial shows a 61 percent (p=0.01) lower risk of Atrial Fibrillation (AF)-related problems in patients who receive a cardiac resynchronization therapy-defibrillator (CRT-D) with the Medtronic-exclusive AdaptivCRT algorithm compared to conventional biventricular pacing therapy. The AdaptivCRT feature is found on market-released Medtronic Viva CRT-D and Viva CRT-P devices. Presented at CARDIOSTIM / EHRA EUROPACE 2014, World Congress in Electrophysiology and Cardiac Techniques, the data also indicate a 55 percent relative reduction in healthcare utilizations (HCUs, including hospitalizations, emergency department or clinic visits) when patients have devices with AdaptivCRT. Patients with Heart Failure, which is a progressive disease, are more likely than the general population to develop AF. AF is associated with worsening heart failure symptoms and higher mortality, along with patients' increased use of healthcare resources.

Previous data from this trial showed patients with Heart Failure who received the AdaptivCRT technology were at a 46 percent lower risk of spending 48 consecutive hours or more in AF compared to conventional CRT patients. According to the analysis of 476 patients, potential use of healthcare resources because of AF are reduced with the AdaptivCRT technology; specific data was presented for the healthcare systems in the United States and Germany, which showed AF-related provider cost savings of $630 USD per patient and �130 over 24 months, respectively. Nearly all of these cost savings (92 percent in the U.S., 93 percent in Germany) were from a reduction in hospitalizations.

Recent data presented at Heart Rhythm 2014 from the Adaptive CRT trial also showed that the AdaptivCRT feature reduced 30-day readmissions for Heart Failure by nearly half, and 30-day readmissions for all-cause hospitalizations by more than 40 percent, which are both noteworthy since readmissions within 30 days of discharge may result in reduced or no payment under many payment settings.